Clinical Trials Logo

Filter by:
NCT ID: NCT05852028 Recruiting - Lymphoma Clinical Trials

A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

Start date: December 15, 2022
Phase:
Study type: Observational

This study aims to observe and explore the efficacy and safety of selinexor-based regimen in patients with Non-Hodgkin lymphoma

NCT ID: NCT05851911 Recruiting - Clinical trials for Passive Transmission of Maternal and Infant Antibodies

Passive Transmission of COVID-19 Antibody From Mother to Infant

Start date: September 1, 2022
Phase:
Study type: Observational

At present, there is no relevant research focusing on children's acquisition of novel coronavirus antibodies through maternal passive transmission. Therefore, this study assessed the changes of maternal passive transmission of COVID-19 antibodies by monitoring the specific antibodies of COVID-19 in young children; This will lay a foundation for further exploring the risk of COVID-19 infection in children and formulating immune prevention strategies.

NCT ID: NCT05851833 Completed - Clinical trials for Length of Hospital Stay

A Retrospective Study of Early Postoperative Mobilization in the Recovery of Patients With Oral Head and Neck Tumors Who Underwent Flap Reconstruction

Start date: March 1, 2020
Phase:
Study type: Observational

All patients with head and neck cancers and osteomyelitis who underwent vascularized flap reconstruction at Shanghai Ninth People's Hospital (North Campus), Shanghai Jiao Tong University, from February 2020 to July 2021 were the object of a retrospective data collection.Depending on whether they had postoperative early mobilization, all patients were split into experimental and control groups.In the experimental group, patients were split into two groups based on the postoperative day(POD): the POD 0-1 group and the POD >1 group.Comparison and analysis were done on the difference in hospital days and post-operative complication rates between the two groups.

NCT ID: NCT05851716 Recruiting - Clinical trials for Artificial Intelligence

Upper Gastrointestinal Endoscopy Reporting System in Improving Report Quality

Start date: August 21, 2023
Phase:
Study type: Observational

The goal of this observational study is to evaluate the effectiveness of an AI-based reporting system for upper gastrointestinal endoscopy. The main question it aims to answer is: Whether the AI-based reporting system can improve the completeness of the reports, which are drafted by endoscopists with the AI assistance. Participants will undergo upper gastrointestinal endoscopy examination as routine. The junior endoscopists will draft the report with the assiatance of the AI system. And the senior and expert endoscopists will draft the report using the traditional reporting system without AI assistance.

NCT ID: NCT05851677 Recruiting - Breast Cancer Clinical Trials

RC48-ADC in Breast Cancer

Start date: June 1, 2023
Phase:
Study type: Observational

To evaluate the efficacy and safety of Disitamab vedotin (RC48-ADC) in patients with breast cancer.

NCT ID: NCT05851456 Recruiting - Sarcoma Clinical Trials

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors

Start date: April 10, 2023
Phase: Early Phase 1
Study type: Interventional

20 participants are expected to be enrolled for this open,Single-armed clinical trial to evaluate the safety and efficacy of the recombinant herpes simplex virus Ⅰ, R130 in patients with relapsed/refractory bone and soft tissue tumors.

NCT ID: NCT05851287 Recruiting - Eye Diseases Clinical Trials

The Aging Eye Cohort Study

AECS
Start date: February 20, 2023
Phase:
Study type: Observational [Patient Registry]

Aging is a major risk factor for many blind-causing eye diseases, e.g., glaucoma, age-related cataracts, and age-related macular degeneration. With the population aging, the impact of lifestyle changes (less time spent outdoors, increasingly sedentary lifestyles, and unhealthy eating habits) on the eye health of the elderly needs further research. This study focuses on establishing a cohort of elderly subjects with normal vision and ocular structure at baseline. The main goal is to study the risk factors for common eye diseases in Chinese elderly population while providing normal-controlled clinical and genomic data for other clinical studies on eye diseases.

NCT ID: NCT05851274 Not yet recruiting - Transradial Access Clinical Trials

Transradial Access for Ruptured Intracranial Aneurysms Embolization

TRA-RIA
Start date: May 10, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trail is to compare the difference between transradial access (TRA) and transfemoral access(TFA) for ruptured intracranial aneurysms embolization. The main question it aims to answer is: whether is TRA not inferior to TFA? In the experimental group, the transradial access (TRA) was used, which was to puncture the radial artery and insert a radial sheath to establish a surgical pathway for embolization of the aneurysm; In the control group, transfemoral access (TFA) was used to embolize the aneurysms, which was to puncture the femoral artery and insert the femoral sheath to establish a surgical pathway for embolizing the aneurysms.The two groups of patients received an oral loading dose of aspirin (300mg) plus clopidogrel (300mg) on the day of surgery, while patients who were unable to take orally were given nasal feeding. During the operation, systemic heparinization was performed with a starting dose of 75U/kg intravenous injection, and the injection was halved every 1h until 1000U. After the operation, protamine neutralizing heparin (1mg protamine neutralizing 100U heparin) was used.

NCT ID: NCT05851261 Completed - Clinical trials for Chronic HBV Infection

Study to Evaluate the Safety, Tolerance, Pharmacokinetics Characteristics of PA3670 Tablets in Chinese Healthy Subjects

Start date: April 13, 2023
Phase: Phase 1
Study type: Interventional

The primary objectives of this study are to evaluate the safety and tolerance of single and multiple oral administration of PA3670 tablets in Chinese adult healthy subjects and the effect of food on pharmacokinetics of PA3670 tablets in Chinese adult healthy subjects.

NCT ID: NCT05851105 Recruiting - a-thalassemia Clinical Trials

the Safety and Efficacy Evaluation of HGI-002 Injection in Patients With Transfusion-Dependent α-Thalassemia

Start date: October 8, 2022
Phase: Early Phase 1
Study type: Interventional

This is an open label study to evaluate the safety and efficacy of α-globin Restored Autologous Hematopoietic Stem Cells in α-Thalassemia Major Patients